TORL BioTherapeutics Raises $158M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Mark Alles. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Porter's run could put pressure on 89-year-old Sen. Dianne Feinstein to confirm a run for re-election. Neither of California's sitting Senators have announced bids.
Launch prices for new cancer drugs continue to escalate with no end in sight, putting breakthrough cures out of reach, concludes a new report from Congresswoman Katie Porter.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment...